8C Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-12-2024
- Paid Up Capital ₹ 1.40 M
as on 24-12-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -18.80%
(FY 2022)
- Profit 93.51%
(FY 2022)
- Ebitda 48.24%
(FY 2022)
- Net Worth 7.61%
(FY 2022)
- Total Assets -8.59%
(FY 2022)
About 8C Healthcare
The Company is engaged in the Professional Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.40 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Palepu, Naresh Pagidimarry, Anil Pegallapati, and Three other members serve as directors at the Company.
- CIN/LLPIN
U33110TG2010PTC066905
- Company No.
066905
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at 8C Healthcare?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naresh Pagidimarry  | Director | 04-Feb-2010 | Current |
| Venkata Palepu | Director | 04-Feb-2010 | Current |
| Anil Pegallapati | Director | 21-Apr-2015 | Current |
| Vikram Bhatnagar | Director | 21-Apr-2015 | Current |
| Sravan Manchikanti | Director | 19-Sep-2012 | Current |
| Vivek Palepu | Director | 04-Feb-2010 | Current |
Financial Performance of 8C Healthcare.
8C Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 18.8% decrease. The company also saw a substantial improvement in profitability, with a 93.51% increase in profit. The company's net worth moved up by a moderate rise of 7.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 8C Healthcare?
In 2017, 8C Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asian Institute Of Spine Endoscopy Private LimitedActive 4 years 11 monthsNaresh Pagidimarry is a mutual person
- Dnr Medinnovations Private LimitedInactive For E-Filing 8 months 5 days
Naresh Pagidimarry is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at 8C Healthcare?
Unlock and access historical data on people associated with 8C Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 8C Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 8C Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
